FDA Inspection
Mary Bird Perkins Cancer CenterMary Bird Perkins Cancer Center – FDA Inspection, Apr 2, 2015
Record Details
This FDA Inspection record concerns Mary Bird Perkins Cancer Center, with an inspection on April 2, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 2, 2015
- Product Type
- Biologics
View Company Profile
ID · 3db77cb5-b711-4a3b-81e6-ea650b52facd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 921199
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Mary Bird Perkins Cancer Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2024 | Not classified | New Orleans District Office | |
| June 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 16, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 29, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 22, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Mary Bird Perkins Cancer Center
- FDA Inspection 1258246 - 2024-12-17
- FDA Inspection 1094459 - 2019-06-06
- FDA Inspection 994363 - 2016-12-16
- FDA Inspection 833712 - 2013-05-29
- FDA Inspection 736189 - 2011-07-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.